Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Rituximab Approval Information - Licensing Action

Proper name: Rituximab
Tradename: Rituxan
Manufacturer: IDEC Pharmaceutical Corp, San Diego, CA, License #1235
Indication for Use: Revise the dosage and administration section of the package insert to include information regarding the use of Rituximab as a component of the Zevalin therapeutic regimen
Approval Date: 2/19/2002
Type of submission: Biologics license application supplement

 

Label (Part 2)

-
-